Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 16
Association Between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease in Euthyroid Subjects: A Cross-Sectional Study [Letter]
Received 9 August 2023
Accepted for publication 10 August 2023
Published 15 August 2023 Volume 2023:16 Pages 2407—2408
DOI https://doi.org/10.2147/DMSO.S434577
Checked for plagiarism Yes
Editor who approved publication: Prof. Dr. Juei-Tang Cheng
Jiaxia Han, Wensheng Lu
Department of Endocrinology, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People’s Republic of China
Correspondence: Wensheng Lu, Email [email protected]
View the original paper by Dr Liu and colleagues
A Response to Letter has been published for this article.
Dear editor
Recently, Liu et al published an original article titled “Association Between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease in Euthyroid Subjects: A Cross-Sectional Study” in Diabetes, Metabolic Syndrome and Obesity-Targets and Therapy.1 Since we are undertaking a pertinent longitudinal cohort study, we are highly interested in this article. We appreciate the authors for their work and congratulate them on their successes.
This study focused primarily on the current hotspot of metabolic dysfunction-associated fatty liver disease (MAFLD) and explored the relationship between thyroid hormone and MAFLD. They concluded that increased free triiodothyronine to free thyroxine (FT3/FT4) ratio and thyroid feedback quantile-based indices (TFQIFT3) were significantly related to MAFLD in populations with euthyroid, in which the triglyceride-glucose (TyG) index played a partial mediating role.
Although we largely concur with the study’s findings, four ambiguous points should be clarified to inform clinical practice properly. Firstly, imbalanced baseline data on the age and gender of recruited subjects will unavoidably affect statistical findings. Secondly, lack of data on Hashimoto thyroiditis-related antibodies, such as thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TGAb) in the euthyroid period. Hashimoto thyroiditis is closely associated with thyroid autoimmunity.2 However, autoimmunity dysfunction is an essential factor for MAFLD.3 Thirdly, lack of data on the critical biochemical indicator vitamin D. Vitamin D plays a significant role in immunoregulation, anti-inflammatory, anti-fibrotic, and insulin sensitivity in hepatic cells and is involved in immune-metabolic pathways within the gut-adipose tissue-liver axis.4 Hypovitaminosis D is associated with NAFLD and steatohepatitis.4 According to reports, hypovitaminosis D is general in the Chinese population.5 Fourthly, this study is a single-center cross-sectional study with a relatively small scale. The conclusion of this study still needs to be confirmed by multicenter and prospective cohort studies.
Despite several flaws, the concerns this article addressed are crucial, and the conclusions have a significant guiding value for clinical practice.
Disclosure
The authors report no conflicts of interest in this communication.
References
1. Liu H, Xing Y, Nie Q, et al. Association between sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects: a cross-sectional study. Diabetes Metab Syndr Obes. 2023;16:2153–2163. doi:10.2147/DMSO.S420872
2. Ludgate M, Emerson CH. Metamorphic thyroid autoimmunity. Thyroid. 2008;18(10):1035–1037. doi:10.1089/thy.2008.1551
3. Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22(7):429–443. doi:10.1038/s41577-021-00639-3
4. Barchetta I, Agata Cimini F, Gisella Cavallo M. Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): an update. Nutrients. 2020;12(11):3302. doi:10.3390/nu12113302
5. Bai K, Dong H, Liu L, et al. Serum 25-hydroxyvitamin D status of a large Chinese population from 30 provinces by LC-MS/MS measurement for consecutive 3 years: differences by age, sex, season and province. Eur J Nutr. 2023;62(3):1503–1516. doi:10.1007/s00394-023-03094-z
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.